E2 ModerateModerate confidencePEM unclearCross-SectionalPeer-reviewedMachine draft
Medication use by persons with chronic fatigue syndrome: results of a randomized telephone survey in Wichita, Kansas.
Jones, James F, Nisenbaum, Rosane, Reeves, William C · Health and quality of life outcomes · 2003 · DOI
Quick Summary
This study looked at what medications and supplements people with ME/CFS use compared to people without the illness. Researchers called people in Wichita, Kansas and identified those with ME/CFS, then invited them to a clinic visit where they reported all their medications and supplements. People with ME/CFS used about twice as many different drugs as healthy people, with pain relievers and vitamins being most common.
Why It Matters
This study documents the substantial medication burden carried by ME/CFS patients, illustrating the widespread need for symptom management across multiple body systems. Understanding medication use patterns can inform clinical care, identify potential drug interactions, and highlight the urgent need for evidence-based treatments targeting underlying disease mechanisms rather than just symptom relief.
Observed Findings
- CFS subjects reported using 316 different drugs compared to 157 in controls
- CFS patients were significantly more likely to use any drug category compared to non-fatigued controls (p = 0.0009)
- Pain relievers and vitamins/supplements were the two most commonly used agents in both groups
- Sex-adjusted odds ratios for specific drug categories ranged from 2.97 to 12.78, with highest risk for certain medication classes
- Higher odds ratios observed for pain relievers, hormones, antidepressants, benzodiazepines, gastrointestinal, and CNS medications in CFS group
Inferred Conclusions
- CFS patients use substantially more medications and supplements than the general population, reflecting unmet symptom management needs
- The pattern of medication use across multiple drug categories suggests CFS involves multiple symptom domains requiring diverse therapeutic approaches
- Current available treatments are primarily symptomatic rather than disease-modifying, indicating a gap in pathophysiology-based therapies
Remaining Questions
- What are the specific reasons patients choose particular medications—are these driven by physician recommendation, symptom severity, or trial-and-error?
- Are certain medication combinations more effective than others for managing CFS symptoms?
What This Study Does Not Prove
This study does not establish whether medications are effective, whether CFS causes medication use or vice versa, or why patients use these medications. The cross-sectional design means we cannot determine the temporal relationship between illness onset and medication initiation, nor can we assess medication safety or outcomes in this population.
Tags
Symptom:PainFatigue
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1186/1477-7525-1-74
- PMID
- 14651754
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →